Bone tissue response to plasma-nitrided titanium implant surfaces

FAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOA current goal of dental implant research is the development of titanium (Ti) surfaces to improve osseointegration. Plasma nitriding treatments generate surfaces that favor osteoblast differentiation, a key event to the process of osteogenesis. Based on this, it is possible to hypothesize that plasma-nitrided Ti implants may positively impact osseointegration. Objective: The aim of this study was to evaluate the in vivo bone response to Ti surfaces modified by plasma-nitriding treatments. Material and Methods: Surface treatments consisted of 20% N-2 and 80% H-2, 450 degrees C and 1.5 mbar during 1 h for planar and 3 h for hollow cathode. Untreated surface was used as control. Ten implants of each surface were placed into rabbit tibiae and 6 weeks post-implantation they were harvested for histological and histomorphometric analyses. Results: Bone formation was observed in contact with all implants without statistically significant differences among the evaluated surfaces in terms of bone-to-implant contact, bone area between threads, and bone area within the mirror area. Conclusion: Our results indicate that plasma nitriding treatments generate Ti implants that induce similar bone response to the untreated ones. Thus, as these treatments improve the physico-chemical properties of Ti without affecting its biocompatibility, they could be combined with modifications that favor bone formation in order to develop new implant surfaces.A current goal of dental implant research is the development of titanium (Ti) surfaces to improve osseointegration. Plasma nitriding treatments generate surfaces that favor osteoblast differentiation, a key event to the process of osteogenesis. Based on this, it is possible to hypothesize that plasma-nitrided Ti implants may positively impact osseointegration. The aim of this study was to evaluate the in vivo bone response to Ti surfaces modified by plasma-nitriding treatments. Surface treatments consisted of 20% N-2 and 80% H-2, 450 degrees C and 1.5 mbar during 1 h for planar and 3 h for hollow cathode. Untreated surface was used as control. Ten implants of each surface were placed into rabbit tibiae and 6 weeks post-implantation they were harvested for histological and histomorphometric analyses. Results: Bone formation was observed in contact with all implants without statistically significant differences among the evaluated surfaces in terms of bone-to-implant contact, bone area between threads, and bone area within the mirror area. Our results indicate that plasma nitriding treatments generate Ti implants that induce similar bone response to the untreated ones. Thus, as these treatments improve the physico-chemical properties of Ti without affecting its biocompatibility, they could be combined with modifications that favor bone formation in order to develop new implant surfacesUSP/Faculdade de Odontologia de Bauru231913FAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOFAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOsem informaçãosem informaçãoBauru, S

Oral mucocele exhibiting an extraoral swelling: a case report of an atypical presentation

ABSTRACT Despite being common pathological entities found in the oral cavity, oral mucoceles can present distinct features, raising several diagnostic possibilities and treatments. In this study, we report the case of a 34-year-old man with an asymptomatic increased volume in the left periorbital region of more than a year, without remission or associated trauma. An aspiration biopsy was performed, followed by an excisional biopsy, and the specimen was sent for histopathological examination. Results led to the diagnosis of an oral mucocele. Surgical removal was performed in an excisional biopsy. Subsequently, the patient recovered promptly without further complications. Although oral mucoceles recur relatively often, its prognosis is good. This case emphasizes the importance of obtaining a detailed disease history, knowledge of its clinical features, and etiopathogenesis combined with complementary examinations to establish diagnostic hypotheses and converge on an adequate and individualized treatment pla

Bone tissue response to plasma-nitrided titanium implant surfaces

A current goal of dental implant research is the development of titanium (Ti) surfaces to improve osseointegration. Plasma nitriding treatments generate surfaces that favor osteoblast differentiation, a key event to the process of osteogenesis. Based on this, it is possible to hypothesize that plasma-nitrided Ti implants may positively impact osseointegration. Objective The aim of this study was to evaluate the in vivo bone response to Ti surfaces modified by plasma-nitriding treatments. Material and Methods Surface treatments consisted of 20% N2 and 80% H2, 450°C and 1.5 mbar during 1 h for planar and 3 h for hollow cathode. Untreated surface was used as control. Ten implants of each surface were placed into rabbit tibiae and 6 weeks post-implantation they were harvested for histological and histomorphometric analyses. Results Bone formation was observed in contact with all implants without statistically significant differences among the evaluated surfaces in terms of bone-to-implant contact, bone area between threads, and bone area within the mirror area. Conclusion Our results indicate that plasma nitriding treatments generate Ti implants that induce similar bone response to the untreated ones. Thus, as these treatments improve the physico-chemical properties of Ti without affecting its biocompatibility, they could be combined with modifications that favor bone formation in order to develop new implant surfaces

Tissue engineering: the effect of the association between cells and Biosilicate® with two crystalline phases (BioS-2P) on bone repair

A crescente demanda clínica para regeneração óssea tem dirigido esforços significativos para o desenvolvimento de novos biomateriais, incluindo aqueles aplicados em terapias baseadas em engenharia de tecidos. Neste contexto, os biovidros são considerados uma boa alternativa mas as suas propriedades mecânicas têm limitado a sua aplicação. Para melhorar tais propriedades sem afetar a biocompatibilidade, um novo material vitrocerâmico bioativo do sistema P2O5-Na2O-CaO-SiO2, chamado Biosilicato® com duas fases cristalinas (BioS-2P) foi desenvolvido. No entanto, os efeitos da adição das fases cristalinas sobre o comportamento biológico do BioS-2P ainda não foram estudados. Assim, os objetivos deste estudo foram investigar a capacidade do BioS-2P em induzir, in vitro, a diferenciação osteoblástica de células-tronco mesenquimais (CTMs); a capacidade do BioS-2P em aumentar, in vitro, a atividade dos osteoblastos em fase inicial de diferenciação (OBs) e osteoblastos da linhagem UMR-106 (UMRs); e a capacidade do BioS-2P em conduzir e induzir a neoformação óssea, in vivo, associado ou não a células. Células derivadas da medula óssea obtidas de fêmures de ratos foram cultivadas em meio de crescimento para obtenção de CTMs ou em meio osteogênico para obtenção de OBs. Essas células e UMRs foram cultivadas sobre discos de BioS-2P, Bioglass® 45S5 (45S5) e plástico de cultura (Controle) e utilizadas nas avaliações in vitro. Para as avaliações in vivo, defeitos de 5 mm criados em calotas de ratos foram implantados somente com arcabouços de BioS-2P ou com arcabouços de BioS-2P associados às CTMs ou aos OBs. Os dados foram comparados por teste não paramétrico de Kruskal-Wallis seguido pelo teste de Student Newman-Keuls, e o nível de significância adotado foi de 5%. As CTMs foram caracterizadas por apresentarem alta porcentagem de células expressando os marcadores de superfície CD29 e CD90 e baixa porcentagem expressando CD31, CD34, CD45 e CD106. A diferenciação osteoblástica das CTMs foi confirmada pela expressão dos genes marcadores da diferenciação osteoblástica fosfatase alcalina (ALP), runt-related transcriptor factor-2 (RUNX2), sialoproteína óssea (BSP) e osteocalcina (OC). CTMs cultivadas sobre discos de BioS-2P em meio não-osteogênico apresentaram diminuição da proliferação e aumento da atividade de ALP e da expressão dos genes marcadores da diferenciação osteoblástica ALP, RUNX2, osterix (OSX), proteína óssea morfogenética-4 (BMP-4), osteopontina (OPN) e OC, comprovando seu potencial osteoindutor similar ao 45S5. O BioS-2P foi capaz de aumentar a atividade de OBs e UMRs de maneira similar àqueles cultivados sobre o 45S5. OBs apresentaram diminuição na proliferação e aumento da atividade da ALP e da expressão dos genes marcadores da diferenciação osteoblástica RUNX2, OSX, BMP-4, OPN e OC. A análise em larga escala da expressão de mais de 23.000 genes mostrou que o BioS-2P induziu a sobre-expressão de genes envolvidos no aumento da atividade osteoblástica e a repressão de genes envolvidos na diminuição dessa atividade, em comparação com o Controle. Ao menos em parte, esse aumento da atividade osteoblástica foi atribuído à modulação das vias de sinalização proteíno-quinases ativadas por mitógenos (MAPK) e Wnt Canônica, e à modulação da expressão de microRNAs. UMRs crescidos sobre o BioS-2P corroboraram esses achados, pela capacidade em formar matriz mineralizada e por apresentarem aumento na expressão das proteínas ALP, RUNX2, dentin matrix protein-1 (DMP-1) e OPN. Arcabouços de BioS-2P (5 mm de diâmetro e 2 mm de altura com porosidade de 76 ± 5% e com tamanhos de poros variando entre 100 e 800 µm) implantados em defeitos na calota de ratos estimularam a formação de tecido ósseo, que ocorreu tanto na periferia como no interior dos defeitos e em íntimo contato com o material. A morfometria por microtomografia computadorizada não evidenciou qualquer diferença entre os parâmetros volume ósseo, volume ósseo/volume total, superfície óssea, superfície/volume ósseo, número de trabéculas, separação trabecular e espessura trabecular, avaliados na 4a, 8a e 12a semanas de implantação. As CTMs e os OBs foram carreados para os arcabouços de BioS- 2P (com eficiência de 90% e 81%, respectivamente) e essas células permaneceram nos defeitos por 14 dias. A combinação de arcabouços de BioS-2P com CTMs ou OBs, implantados por 8 semanas, resultou no mesmo padrão de formação óssea daquele observado para o arcabouço sem células. No entanto, essa combinação não resultou em aumento na quantidade de osso formado. Os resultados evidenciaram a capacidade do BioS-2P em induzir a diferenciação osteoblástica de CTMs e estimular a atividade osteoblástica de OBs, o que resultaria na neoformação óssea observada in vivo. No entanto, a combinação de BioS-2P com CTMs e OBs não foi capaz de aumentar a formação óssea e induzir o reparo dos defeitos ósseos.The increasing clinical demand for bone regeneration has driven significant efforts to develop new biomaterials including those for tissue engineeringbased therapies. In this context, bioglasses emerges as a good alternative, but their use has been limited mainly due their poor mechanical properties. To improve these mechanical properties without affecting biocompatibility, a novel bioactive glass-ceramic of the P2O5-Na2O-CaO-SiO2 system, named Biosilicate® with two cristallyne phases (BioS-2P) was developed. However, the effects of these two phases on BioS- 2P biological behavior have not yet been evaluated. Thus, the aims of this study were to investigate the BioS-2P capability of inducing in vitro mesenquimal stem cell differentiation (MSC) towards osteoblasts; the BioS-2P capability to increase in vitro activity of osteoblasts derived from rat bone marrow at early stages of differentiation (OBs) and osteoblasts from rat cell line UMR- 106 (UMRs); and the BioS-2P capability to drive and induce bone formation in vivo, associated or not with cells. Bone marrow cells harvested from rat femurs were cultured either in growth media to obtain MSCs or in osteogenic media to obtain OBs. MSCs, OBs and UMRs were cultured on discs of BioS-2P, Bioglass® 45S5 (45S5) and tissue culture polystyrene (Control). For in vivo evaluations, 5-mm rat calvarial surgical defects were filled with BioS-2P with or without MSCs or OBs. Data were compared by non-parametric Kruskal-Wallis test followed by Student Newman- Keuls test and the significance level was set at 5%. MSCs were characterized by presenting high percentage of CD29 and CD90 surface markers and low percentage of CD31, CD34, CD45 and CD106 surface markers. Osteoblastic differentiation of MSCs was detected by gene expression of bone markers alkaline phosphatase (ALP), runt-related transcritption factor 2 (RUNX2), bone sialoprotein (BSP) and osteocalcin (OC). MSCs cultured on Bios-2P discs under non-osteogenic conditions exhibited a decrease on cell proliferation and an increase on ALP activity and gene expression of bone markers ALP, RUNX2, osterix (OSX), bone morphogenetic protein-4 (BMP-4), osteopontin (OPN) and OC, confirming its osteoinductive potential similar to 45S5. Also, BioS-2P increased the OBs and UMRs activity, similar to 45S5. OBs cultured on Bios-2P discs presented a decrease in cell proliferation and an increase on ALP activity and gene expression of bone markers RUNX2, OSX, BMP-4, OPN and OC. The large-scale analysis of over 23,000 genes showed that the BioS-2P induced overexpression of genes positively related to osteoblastic activity and repression of genes negatively related with its activity, compared with control. At least in part, the increase on OBs activity was associated to the modulation of two main signaling pathways, the mitogen activated protein kinases (MAPK) and the Canonical Wnt, and the modulation of microRNAs expression. These findings were corroborated by UMRs grown on BioS-2P, which produced mineralized matrix and exhibited increased expression of the ALP, RUNX2, dentin matrix protein-1 (DMP-1) and OPN proteins, than on control. BioS-2P scaffolds (5 mm diameter and 2 mm heigh, presenting 76 ± 5% of total porosity, with poros size ranging from 100 to 800 µm) implanted in calvarial defects promoted new bone formation in close contatc to BioS-2P, both on periphery and in the center of the defect. The computed microtomography morphometry showed no difference between the evaluated parameters bone volume, bone volume / total volume, bone surface, surface / bone volume, number of trabeculae, trabecular separation and trabecular thickness, measured at 4, 8 and 12 weeks. MSCs and OBs were seeded into the scaffold (with efficiency of incorporation 90% e 81%, respectively) and they remained on the defects for 14 days. After 8 weeks, the same pattern of bone formation was observed, however, the combination of BioS-2P with cells did not increase the amount of new bone. The results showed the BioS-2P ability to induce osteoblastic differentiation of MSCs and to stimulate osteoblastic activity, resulting in new bone formation in vivo. However, the combination of BioS-2P with MSCs and OBs was not able to increase bone formation and induce the repair of bone defects

Tissue engineering: the effect of the association between cells and Biosilicate® with two crystalline phases (BioS-2P) on bone repair

A crescente demanda clínica para regeneração óssea tem dirigido esforços significativos para o desenvolvimento de novos biomateriais, incluindo aqueles aplicados em terapias baseadas em engenharia de tecidos. Neste contexto, os biovidros são considerados uma boa alternativa mas as suas propriedades mecânicas têm limitado a sua aplicação. Para melhorar tais propriedades sem afetar a biocompatibilidade, um novo material vitrocerâmico bioativo do sistema P2O5-Na2O-CaO-SiO2, chamado Biosilicato® com duas fases cristalinas (BioS-2P) foi desenvolvido. No entanto, os efeitos da adição das fases cristalinas sobre o comportamento biológico do BioS-2P ainda não foram estudados. Assim, os objetivos deste estudo foram investigar a capacidade do BioS-2P em induzir, in vitro, a diferenciação osteoblástica de células-tronco mesenquimais (CTMs); a capacidade do BioS-2P em aumentar, in vitro, a atividade dos osteoblastos em fase inicial de diferenciação (OBs) e osteoblastos da linhagem UMR-106 (UMRs); e a capacidade do BioS-2P em conduzir e induzir a neoformação óssea, in vivo, associado ou não a células. Células derivadas da medula óssea obtidas de fêmures de ratos foram cultivadas em meio de crescimento para obtenção de CTMs ou em meio osteogênico para obtenção de OBs. Essas células e UMRs foram cultivadas sobre discos de BioS-2P, Bioglass® 45S5 (45S5) e plástico de cultura (Controle) e utilizadas nas avaliações in vitro. Para as avaliações in vivo, defeitos de 5 mm criados em calotas de ratos foram implantados somente com arcabouços de BioS-2P ou com arcabouços de BioS-2P associados às CTMs ou aos OBs. Os dados foram comparados por teste não paramétrico de Kruskal-Wallis seguido pelo teste de Student Newman-Keuls, e o nível de significância adotado foi de 5%. As CTMs foram caracterizadas por apresentarem alta porcentagem de células expressando os marcadores de superfície CD29 e CD90 e baixa porcentagem expressando CD31, CD34, CD45 e CD106. A diferenciação osteoblástica das CTMs foi confirmada pela expressão dos genes marcadores da diferenciação osteoblástica fosfatase alcalina (ALP), runt-related transcriptor factor-2 (RUNX2), sialoproteína óssea (BSP) e osteocalcina (OC). CTMs cultivadas sobre discos de BioS-2P em meio não-osteogênico apresentaram diminuição da proliferação e aumento da atividade de ALP e da expressão dos genes marcadores da diferenciação osteoblástica ALP, RUNX2, osterix (OSX), proteína óssea morfogenética-4 (BMP-4), osteopontina (OPN) e OC, comprovando seu potencial osteoindutor similar ao 45S5. O BioS-2P foi capaz de aumentar a atividade de OBs e UMRs de maneira similar àqueles cultivados sobre o 45S5. OBs apresentaram diminuição na proliferação e aumento da atividade da ALP e da expressão dos genes marcadores da diferenciação osteoblástica RUNX2, OSX, BMP-4, OPN e OC. A análise em larga escala da expressão de mais de 23.000 genes mostrou que o BioS-2P induziu a sobre-expressão de genes envolvidos no aumento da atividade osteoblástica e a repressão de genes envolvidos na diminuição dessa atividade, em comparação com o Controle. Ao menos em parte, esse aumento da atividade osteoblástica foi atribuído à modulação das vias de sinalização proteíno-quinases ativadas por mitógenos (MAPK) e Wnt Canônica, e à modulação da expressão de microRNAs. UMRs crescidos sobre o BioS-2P corroboraram esses achados, pela capacidade em formar matriz mineralizada e por apresentarem aumento na expressão das proteínas ALP, RUNX2, dentin matrix protein-1 (DMP-1) e OPN. Arcabouços de BioS-2P (5 mm de diâmetro e 2 mm de altura com porosidade de 76 ± 5% e com tamanhos de poros variando entre 100 e 800 µm) implantados em defeitos na calota de ratos estimularam a formação de tecido ósseo, que ocorreu tanto na periferia como no interior dos defeitos e em íntimo contato com o material. A morfometria por microtomografia computadorizada não evidenciou qualquer diferença entre os parâmetros volume ósseo, volume ósseo/volume total, superfície óssea, superfície/volume ósseo, número de trabéculas, separação trabecular e espessura trabecular, avaliados na 4a, 8a e 12a semanas de implantação. As CTMs e os OBs foram carreados para os arcabouços de BioS- 2P (com eficiência de 90% e 81%, respectivamente) e essas células permaneceram nos defeitos por 14 dias. A combinação de arcabouços de BioS-2P com CTMs ou OBs, implantados por 8 semanas, resultou no mesmo padrão de formação óssea daquele observado para o arcabouço sem células. No entanto, essa combinação não resultou em aumento na quantidade de osso formado. Os resultados evidenciaram a capacidade do BioS-2P em induzir a diferenciação osteoblástica de CTMs e estimular a atividade osteoblástica de OBs, o que resultaria na neoformação óssea observada in vivo. No entanto, a combinação de BioS-2P com CTMs e OBs não foi capaz de aumentar a formação óssea e induzir o reparo dos defeitos ósseos.The increasing clinical demand for bone regeneration has driven significant efforts to develop new biomaterials including those for tissue engineeringbased therapies. In this context, bioglasses emerges as a good alternative, but their use has been limited mainly due their poor mechanical properties. To improve these mechanical properties without affecting biocompatibility, a novel bioactive glass-ceramic of the P2O5-Na2O-CaO-SiO2 system, named Biosilicate® with two cristallyne phases (BioS-2P) was developed. However, the effects of these two phases on BioS- 2P biological behavior have not yet been evaluated. Thus, the aims of this study were to investigate the BioS-2P capability of inducing in vitro mesenquimal stem cell differentiation (MSC) towards osteoblasts; the BioS-2P capability to increase in vitro activity of osteoblasts derived from rat bone marrow at early stages of differentiation (OBs) and osteoblasts from rat cell line UMR- 106 (UMRs); and the BioS-2P capability to drive and induce bone formation in vivo, associated or not with cells. Bone marrow cells harvested from rat femurs were cultured either in growth media to obtain MSCs or in osteogenic media to obtain OBs. MSCs, OBs and UMRs were cultured on discs of BioS-2P, Bioglass® 45S5 (45S5) and tissue culture polystyrene (Control). For in vivo evaluations, 5-mm rat calvarial surgical defects were filled with BioS-2P with or without MSCs or OBs. Data were compared by non-parametric Kruskal-Wallis test followed by Student Newman- Keuls test and the significance level was set at 5%. MSCs were characterized by presenting high percentage of CD29 and CD90 surface markers and low percentage of CD31, CD34, CD45 and CD106 surface markers. Osteoblastic differentiation of MSCs was detected by gene expression of bone markers alkaline phosphatase (ALP), runt-related transcritption factor 2 (RUNX2), bone sialoprotein (BSP) and osteocalcin (OC). MSCs cultured on Bios-2P discs under non-osteogenic conditions exhibited a decrease on cell proliferation and an increase on ALP activity and gene expression of bone markers ALP, RUNX2, osterix (OSX), bone morphogenetic protein-4 (BMP-4), osteopontin (OPN) and OC, confirming its osteoinductive potential similar to 45S5. Also, BioS-2P increased the OBs and UMRs activity, similar to 45S5. OBs cultured on Bios-2P discs presented a decrease in cell proliferation and an increase on ALP activity and gene expression of bone markers RUNX2, OSX, BMP-4, OPN and OC. The large-scale analysis of over 23,000 genes showed that the BioS-2P induced overexpression of genes positively related to osteoblastic activity and repression of genes negatively related with its activity, compared with control. At least in part, the increase on OBs activity was associated to the modulation of two main signaling pathways, the mitogen activated protein kinases (MAPK) and the Canonical Wnt, and the modulation of microRNAs expression. These findings were corroborated by UMRs grown on BioS-2P, which produced mineralized matrix and exhibited increased expression of the ALP, RUNX2, dentin matrix protein-1 (DMP-1) and OPN proteins, than on control. BioS-2P scaffolds (5 mm diameter and 2 mm heigh, presenting 76 ± 5% of total porosity, with poros size ranging from 100 to 800 µm) implanted in calvarial defects promoted new bone formation in close contatc to BioS-2P, both on periphery and in the center of the defect. The computed microtomography morphometry showed no difference between the evaluated parameters bone volume, bone volume / total volume, bone surface, surface / bone volume, number of trabeculae, trabecular separation and trabecular thickness, measured at 4, 8 and 12 weeks. MSCs and OBs were seeded into the scaffold (with efficiency of incorporation 90% e 81%, respectively) and they remained on the defects for 14 days. After 8 weeks, the same pattern of bone formation was observed, however, the combination of BioS-2P with cells did not increase the amount of new bone. The results showed the BioS-2P ability to induce osteoblastic differentiation of MSCs and to stimulate osteoblastic activity, resulting in new bone formation in vivo. However, the combination of BioS-2P with MSCs and OBs was not able to increase bone formation and induce the repair of bone defects

Titanium surfaces modified by plasma: in vitro evaluation in osteoblastic cell cultures

As pesquisas na área da implantologia têm buscado desenvolver superfícies que acelerem o processo de osseointegração adjacente ao implante, permitindo a reabilitação funcional e estética precoce. Modificações da topografia e composição química têm sido propostas com o objetivo de modular as funções celulares na interface do tecido ósseo com o implante e, em última análise, aumentar o contato osso-implante. A deposição iônica por plasma é uma modalidade de tratamento utilizada em implantes ortopédicos. Na odontologia, estudos têm avaliado o efeito das diferentes técnicas de nitretação de superfícies de titânio (Ti) sobre eventos iniciais da osseointegração, como a adesão celular, mas não sobre eventos tardios. O presente estudo avaliou o efeito de superfícies de Ti modificadas por deposição iônica por plasma, pelas técnicas de nitretação por cátodo oco, por 1 e 3 h, e nitretação planar, nas expressões do fenótipo e gênica de osteoblastos derivados de osso alveolar de humanos e de calvária de ratos. Foram realizadas análises de morfologia, adesão e espraiamento celular, síntese e atividade de fosfatase alcalina (ALP), mineralização da matriz extracelular e expressão de genes marcadores do fenótipo osteoblástico. A adesão celular e a atividade de ALP, foram maiores nas superfícies de Ti tratadas comparadas à superfície sem tratamento (controle), enquanto a proliferação celular e a produção de matriz mineralizada não apresentaram diferenças estatisticamente significante entre os grupos. Ainda, as superfícies de Ti tratadas aumentaram a expressão gênica de ALP e diminuíram a de osteocalcina (OC) quando comparadas à superfície controle. Os resultados sugerem que a deposição iônica por plasma pelas técnicas de nitretação avaliadas modifica as características físico-químicas da superfície de Ti e promove atraso e aumento da diferenciação osteoblástica quando comparada à superfície de Ti não tratada.A current goal in implantology research has been the development of titanium surfaces to enhance the process of osseointegration, allowing functional and aesthetic rehabilitation. Modifications on topography and chemical composition have been proposed in order to regulate cell functions of the osteoblasts in contact with the implant surface and ultimately increase the bone-to-implant contact. Plasma ionic deposition is a treatment usually employed in orthopedic implants and in dentistry some studies have shown that different nitriding techniques of titanium (Ti) surfaces may affect the initial events of osseointegration, such as cell adhesion, without evaluating the late ones. This study evaluated the effect of Ti surfaces modified by plasma nitriding combined with hollow cathode, during 1 and 3 h, and planar nitriding, on the phenotype and gene expression of osteoblasts derived from human alveolar bone and newborn rat calvaria. Cell morphology, adhesion and spreading, alkaline phosphatase (ALP) activity and synthesis, extracellular matrix mineralization and gene expression of bone markers were performed. The cell adhesion and ALP activity were higher on treated Ti surfaces compared with untreated (control) ones, while cell proliferation and extracellular matrix mineralization were not affected by the treatments. Also, compared with control Ti surface, the treated ones increased the gene expression of ALP and reduced osteocalcin (OC). The results suggest that the plasma ionic deposition by nitriding technique modifies the physicochemical features of the Ti surface and promotes a delay and a enhancement of the osteoblastic differentiation compared with untreated Ti surface

Effect of ZrO2 content on ageing resistance and osteogenic cell differentiation of ZrO2-Al2O3 composite

Two commercial 3 mol% yttria-partially stabilized zirconia powders, with 0.3 wt% Al2O3 (YZA) and without Al2O3 (YZ), were used to produce alumina (Al2O3)-zirconia (ZrO2) slip cast composites. The influence of the ZrO2 content and the ZrO2 grain size on the ageing behavior of the different Al2O3-ZrO2 composites was investigated. In addition, the in vitro biocompatibility and osteogenic cell differentiation of Al2O3-ZrO2 surfaces were evaluated before ageing (ba) and after ageing (aa) using the rat bone marrow-derived osteoblast cell culture model; the osteogenic potential of preosteoblast MC3T3-E1 cells on the same surfaces was also assessed. The ageing susceptibility of the composites significantly increased with increasing the ZrO2 content over 22 vol%. For ZrO2 contents ≤22 vol%, the grain size did not influence the transformability of tetragonal ZrO2 under ageing conditions; however, in the composites with 50 vol%, the greater grain size of 50 vol% YZ with respect to 50 vol% YZA enhanced the ageing degradation. Overall, the cell culture experiments revealed no significant differences among the composites before ageing in terms of osteogenic cell differentiation, except for the higher mineralization of bone marrow-derived osteoblast cells grown on 50 vol% YZ ba compared with the ones grown on 50 vol% YZA ba. The ageing process tended to rescue the osteogenic potential of these cells grown on 50 vol% YZA while inhibiting the one on 50 vol% YZ. In conclusion, the low ageing sensitive of the composites with ZrO2 contents ≤22 vol% did not change the osteoblast biocompatibility, whereas the greater ageing degradation of the composites with 50 vol% ZrO2 seemed to alter the osteogenic potential of bone marrow-derived osteoblast cells.Fil: Albano, Maria Patricia. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas. Centro de Tecnología de Recursos Minerales y Cerámica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Tecnología de Recursos Minerales y Cerámica; ArgentinaFil: Calambas Pulgarin, Heydy Lorena. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas. Centro de Tecnología de Recursos Minerales y Cerámica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Tecnología de Recursos Minerales y Cerámica; ArgentinaFil: Garrido, Liliana Beatriz. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas. Centro de Tecnología de Recursos Minerales y Cerámica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Tecnología de Recursos Minerales y Cerámica; ArgentinaFil: Ferraz, Emanuela Prado. Universidade de Sao Paulo; BrasilFil: Rosa, Adalberto L.. Universidade de Sao Paulo; BrasilFil: De Oliveira, Paulo Tambasco. Universidade de Sao Paulo; Brasi

Mesenchymal Stem Cells Combined with a P(VDF-TrFE)/BaTiO₃ Scaffold and Photobiomodulation Therapy Enhance Bone Repair in Rat Calvarial Defects

Background: Tissue engineering and cell therapy have been the focus of investigations on how to treat challenging bone defects. This study aimed to produce and characterize a P(VDF-TrFE)/BaTiO3 scaffold and evaluate the effect of mesenchymal stem cells (MSCs) combined with this scaffold and photobiomodulation (PBM) on bone repair. Methods and results: P(VDF-TrFE)/BaTiO3 was synthesized using an electrospinning technique and presented physical and chemical properties suitable for bone tissue engineering. This scaffold was implanted in rat calvarial defects (unilateral, 5 mm in diameter) and, 2 weeks post-implantation, MSCs were locally injected into these defects (n = 12/group). Photobiomodulation was then applied immediately, and again 48 and 96 h post-injection. The μCT and histological analyses showed an increment in bone formation, which exhibited a positive correlation with the treatments combined with the scaffold, with MSCs and PBM inducing more bone repair, followed by the scaffold combined with PBM, the scaffold combined with MSCs, and finally the scaffold alone (ANOVA, p ≤ 0.05). Conclusions: The P(VDF-TrFE)/BaTiO3 scaffold acted synergistically with MSCs and PBM to induce bone repair in rat calvarial defects. These findings emphasize the need to combine a range of techniques to regenerate large bone defects and provide avenues for further investigations on innovative tissue engineering approaches